Healthcare · Vaccine antigens production
Norway does not produce vaccine antigens — the indicator is 10 million doses. The country lacks large-scale manufacturing facilities for vaccines, focusing instead on importing finished products and developing biotechnological research. Instead, Norway actively invests in developing new treatments and diagnostics, especially in oncology and rare diseases.
Data for 2026 · unit: million doses
Position
#17 / 197
Norway world ranking
Country position on the scale from last to first place for this indicator.
NO
#17
#197#1
Trend
Change over time
Change in indicator over the available period.
1
1950
8
1990
15
2000
10
2010
20
2020
10
2025
10
2026
Values — million doses
Comparison
Top countries by Vaccine antigens production
Where Norway stands in the world ranking.
1
CNChina
5 K
2
USUSA
500
3
BRBrazil
400
4
FRFrance
160
5
INIndia
100
5
RURussia
100
7
CACanada
60
8
AUAustralia
50
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Vaccine antigens production in Norway — how much?
Based on 2026 data — 10 million doses. This is rank #17 out of 197 countries.
What is Norway's rank by Vaccine antigens production?
Norway ranks #17 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Norway?
Over the available period the indicator changed from 1 to 10 million doses.